1 week ago
2
Marco Marca/iStock via Getty Images
- Abbott (NYSE:ABT) announced that it has obtained the CE Mark in Europe for a broader use of its Navitor transcatheter aortic valve implantation system.
- This new approval allows the treatment of patients suffering from symptomatic, severe aortic stenosis who are considered
English (US) ·